Associate Professor of Medicine (Medical Oncology); Chief, Patient Experience Officer; Medical Director, Survivorship Clinic
Yale Cancer Center/Smilow Cancer HospitalCancer, Cancer Prevention and Control, Medical Oncology, Survivorship
am board certified in both medical oncology and hospice and palliative medicine, which I feel helps me treat the "whole person" and not just a disease. As the Chief Patient Experience Officer at Smilow Cancer Hospital, I enjoy thinking about improving care, especially where the provider and patient experience overlaps. As a breast oncologist, I have a busy practice and enjoy taking care of women with newly diagnosed breast cancer. As the director of the Yale Survivorship Clinic, one of the nation鈥檚 only multi-disciplinary clinics specializing in cancer survivorship, I learn from patients about key issues after treatment and this informs my role as Chair of the NCCN Survivorship Guidelines. My research focuses on healthy lifestyles and quality of life after cancer. I am a facilitator for Relationship-Centered Communication Workshop that address how we develop therapeutic relationships with our patients and each other. Learn more about Dr. Tara Sanft>> Education & Training Fellowship Northwestern University, Chicago, Illinois (2010) Fellowship Northwestern University, Chicago, Illinois (2010) Resident Northwestern University Feinberg School of Medicine (2007) MD Medical College Wisconsin (2004)
Professor of Clinical Medicine (Medical Oncology); Associate CEHE Director, Clinical Research
Yale Cancer Center/Smilow Cancer HospitalCancer Prevention and Control, Clinical Medicine, Disparities, Health Equity, Medical Oncology
Dr. Silber is the Associate CEHE Director for Clinical Research. As a medical oncologist who serves as the Medical Director and Physician Champion of the Centers for Disease Control/Connecticut Department of Public Health's 5-year provider supported grant at Yale New Haven Hospital entitled, The Connecticut Cancer Screening Program (CCSP), she designed the Comprehensive Breast Cancer Outreach and Support Program for Underserved Women, which is a culturally competent program supported by the Breast Cancer Alliance of Greenwich. She has supervised Community Health Educators dating back to 1996, when she received a national Komen award for the Sister to Sister Program, and has been recognized for expertise in breast cancer among African American women. She has directed a cancer clinic for the uninsured and underinsured for two decades and have formed community relationships, which require many years to nurture and demonstrate constancy. This year, she became the principal investigator of the Avon-Pfizer Metastatic Breast Cancer Grants Program: Identify-Amplify-Unify. This program assists organizations that provide information and services to help patients in navigating the medical and emotional challenges associated with their disease. Dr. Silber was awarded this grant from a highly competitive pool of 23 non-profit organizations nationally. Also, this year, CT Health and Educational Facilities Authority (CHEFA) awarded a grant to fund a novel program called 鈥淏reast Cancer S.W.A.T. Team- We鈥檝e got your back!鈥. Learn more about Dr. Silber>> As a principal investigator, she assists economically disadvantaged breast cancer patients to adhere to treatment using medical legal partnership. This year, she was selected to participate as a leadership fellow of the Connecticut Health Foundation. The fellowship was established in 2005, and brings together diverse individuals from multiple sectors who are dedicated to achieving health equity. Each year, the foundation selects up to 20 participants into this competitive ten-month program. Throughout this program, her project has been to increase clinical trial participation among ethnic minorities and capitalize on opportunities created by the Affordable Care Act. On May 1, 2015, she was named Assistant Clinical Director for Diversity and Health Equity at Yale Cancer Center and focuses on engagement with community partners in improving education for prevention and screening and access to cancer care for diverse populations within the local community as well as Greater New Haven area.